In these commentaries, members of the editorial board of Population Health, Equity & Outcomes present their ideas for fixes to the US health care system that could guide health policy efforts post election.
Rare Blood Disease Innovations Address Unmet Needs, According to ASH Data
Revealing Ovarian Cancer Survival Gaps Among Asian American Subgroups
Elacestrant Shows Real-World Effectiveness in Metastatic Breast Cancers
Visual Acuity, OSDI Improved With Use of Hydrogen Peroxide in Dry Eye Caused By Contacts
Cilta-Cel Leads to Prolonged Progression-Free Survival in Multiple Myeloma
Rare Blood Disease Innovations Address Unmet Needs, According to ASH Data
Revealing Ovarian Cancer Survival Gaps Among Asian American Subgroups
Access and Equity: Bispecifics for Multiple Myeloma in the Community Setting
Dr Oz's Medicare Proposals Face Scrutiny From Democrats
Mind the Gap: Addressing Pediatric Sleep Disparities and the Role of Sleep Variability
Ambient Toxins Linked to Disabilities in Minority Schoolchildren
Socioeconomic Factors Limit Access to Stem Cell Transplantation in AML
Health Equity & Access Weekly Roundup: December 7, 2024
New Data Reinforce Iptacopan's Role in Transforming PNH Care With Hemoglobin, QOL Gains
Advancing Women's Health: CVS Health Leader on Access, Technology, and Breaking Stigmas
Discussing the Pathophysiology of Alopecia Areata
Vowst as a Potential Option for Patients With Recurrent C Difficile Infections
Unraveling GLP-1 Agonists and Cardiovascular Protection
Implementing CRM Learnings and Utilization of Telehealth
EMBER-3 Trial: Imlunestrant Plus Abemaciclib Improves Survival in Advanced Breast Cancer
How Anti–CD-38 Antibodies Are Changing the Standard of Myeloma Care
Shorter Duration of Venetoclax Possible for Some Patients With Newly Diagnosed AML
Linvoseltamab Shows Durable Efficacy, Manageable Safety in R/R Multiple Myeloma
Insights on Managing Cough Symptoms in Patients With IPF
Key Data Supporting the Use of Rebyota in Patients With Recurrent C Difficile Infections
Rare Blood Disease Innovations Address Unmet Needs, According to ASH Data
Elacestrant Shows Real-World Effectiveness in Metastatic Breast Cancers
Cilta-Cel Leads to Prolonged Progression-Free Survival in Multiple Myeloma
Access and Equity: Bispecifics for Multiple Myeloma in the Community Setting
Mandatory Medicare Bundled Payment and the Future of Hospital Reimbursement
Impact of Delayed Adoption of Novel Atrial Fibrillation Treatments
Dallas Nephrology Associates’ Journey to Value-Based Care
An Integrated Practice Unit Tool for the Military Health System
Disconnects Between Provider Network Directories and Patient Preferences
Out-of-Pocket Spending for Cardiac Rehabilitation and Adherence Among US Adults
To Improve Clinical Trial Equity in Multiple Myeloma, Just Ask
Collaborating for Cancer Care Equity: Community and Academic Insights
Elevating Value in Cancer Care With Innovations, Accessibility, Equity
Beyond McKesson and Florida Cancer Specialists, Deals Are Reshaping Community Oncology
Evidence-Based Guidelines Point to Leap in Care for Hypertrophic Cardiomyopathy
ASH Annual Meeting Coverage: Highlighting the Recent Updates in TKI Use in the Treatment of CML – Insights and Application for Managed Care
Advances and Best Practices for Managed Care Pharmacists in the Treatment of Heart Failure with Preserved Ejection Fraction
Navigating the Evolving Landscape of HER2-Positive Early-Stage Breast Cancer: Considerations for Managed Care
Child Abuse: Responsibilities and Protection of the Reporter
Recent Advances in BCMA-Directed Treatment in Multiple Myeloma: Insights and Application for Managed Care
Managed Care Approaches to Improve Outcomes in Frontline Therapy for Renal Cell Carcinoma
Challenges in Treatment of Desmoid Tumors and Managed Care Solutions
Desmoid Tumors: What Managed Care Professionals Need to Know to Manage These Unpredictable Tumors, featuring a Pharmacy Focus Podcast
Navigating the Advances in the Treatment of Geographic Atrophy: Updates and Strategies for Managed Care